Foodborne Botulism, a Real Challenge for Infectious Disease Specialists

We herein report a rare case of mycotic aneurysm of the superior mesenteric artery caused by <i>Klebsiella pneumoniae</i>. A 66-year-old man, a known case of hypertension and aorto-oesophageal fistula with stented aorta in 2010 and 2018, presented to the emergency department multiple times over 2 months with severe postprandial abdominal pain associated with vomiting and fever. On his last presentation, the obtained blood cultures grew ESBL positive <i>K. pneumoniae</i> and a repeated computed tomography (CT) showed a growing aneurysm at the origin of the ileocecal branch of the superior mesenteric artery measuring 17 × 10 mm (the aneurysm was 8 × 7.5 mm in the CT angiography on the previous admission). Extensive workup did not reveal the underlying cause of the mycotic aneurysm, thus we believe the cause to be the infected aortic stent, leading to bacteraemia and vegetations to the mesenteric artery causing the aneurysm. The management plan was placed by a multidisciplinary team consisting of vascular surgeons and infectious disease specialists along with review from a dietician to evaluate the patient’s nutritional status. The patient was started on total parenteral nutrition due to his postprandial pain and on antibiotic therapy according to the infectious disease team’s recommendation. He underwent surgical resection of the mycotic aneurysm, which showed a thrombosed aneurysm in the jejunoileal mesenteric area. The histopathology of the resected tissue demonstrated inflammatory aneurysm of the mesenteric artery. Following the surgery, the patient continued his antibiotic therapy and was discharged on the 13th post-operative day with follow-up appointments in the vascular surgery and infectious disease clinic.

Download Full-text

Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa

Clinical Infectious Diseases ◽

10.1093/cid/civ633 ◽

2015 ◽

Vol 61 (6) ◽

pp. 859-863 ◽

Cited By ~ 56

Author(s):

Elie F. Berbari ◽

Souha S. Kanj ◽

Todd J. Kowalski ◽

Rabih O. Darouiche ◽

Andreas F. Widmer ◽

...

Keyword(s):

Infectious Disease ◽

Clinical Practice ◽

Practice Guidelines ◽

Antimicrobial Therapy ◽

Healthcare Professionals ◽

Surgical Intervention ◽

Vertebral Osteomyelitis ◽

Executive Summary ◽

Orthopedic Surgeons ◽

Infectious Disease Specialists

Abstract These guidelines are intended for use by infectious disease specialists, orthopedic surgeons, neurosurgeons, radiologists, and other healthcare professionals who care for patients with native vertebral osteomyelitis (NVO). They include evidence and opinion-based recommendations for the diagnosis and management of patients with NVO treated with antimicrobial therapy, with or without surgical intervention.

Download Full-text

INFECTIOUS AND INFLAMMATORY COMPLICATIONSIN OPHTHALMOLOGYAMID COVID-19

UZBEK MEDICAL JOURNAL ◽

10.26739/2181-0664-2021-5-8 ◽

2021 ◽

Vol 2 (5) ◽

pp. 40-44

Author(s):

Khalidjan Kamilov ◽

◽

Munirakhon Kasimova ◽

Gavkhar Khamraeva ◽

Manzurakhon Rizaeva

Keyword(s):

Infectious Disease ◽

Sinus Thrombosis ◽

Correct Diagnosis ◽

Secondary Glaucoma ◽

Cavernous Sinus Thrombosis ◽

Optic Nerve Atrophy ◽

Ocular Complications ◽

Adequate Treatment ◽

Infectious Disease Specialists ◽

Corneal Penetration

Inflammatory complications of the organ of vision in the time of COVID-19 can be manifested as conjunctivitis, scleritis, episcleritis, keratitis, uveitis and optic neuritis. It is essential to collect anamnesis, examine the blood for the presence of COVID 19 and treat these patients with the help of infectious disease specialists. Correct diagnosis of inflammatory ocular complications in the presence of COVID 19 makes it possible to prevent ocular complications, such as: ulcers and corneal penetration; fusion and overgrowth of the pupil,which leadto secondary glaucoma; endoophthalmitis, panophthalmitis and optic nerve atrophy. Timely intensive medical care and adequate treatment of these complications lead to a decrease in disability in this category of patients.Keywords:Ophthalmology, COVID-19,complications, ulcers, endoophthalmitis, panophthalmitis, gastrointestinal tract, cavernous sinus thrombosis

Download Full-text

Management of complicated skin and skin structure infections – a call for infectious disease specialists

Infectious Diseases ◽

10.1080/23744235.2017.1363405 ◽

2017 ◽

Vol 50 (2) ◽

pp. 117-118

Author(s):

Arne Tärnvik

Keyword(s):

Infectious Disease ◽

Skin Structure ◽

Complicated Skin ◽

Infectious Disease Specialists

Download Full-text

Clinical Management of Heart Transplant Recipients

Mayo Clinic Critical and Neurocritical Care Board Review ◽

10.1093/med/9780190862923.003.0070 ◽

2019 ◽

pp. 443-445

Author(s):

Arzoo Sadiqi ◽

Jama Jahanyar

Keyword(s):

Infectious Disease ◽

Heart Transplant ◽

Clinical Management ◽

Right Ventricular Failure ◽

Team Approach ◽

Transplant Recipients ◽

Multidisciplinary Team Approach ◽

Infectious Disease Specialists ◽

Heart Transplant Recipients ◽

Cardiac Surgeons

The challenges of managing heart transplant recipients postoperatively relate to right ventricular failure, immunosuppression, and the unique physiology of the donor heart. Clinical management of heart transplant recipients requires a multidisciplinary team approach with a coordinated effort between intensivists, cardiac surgeons, heart transplant cardiologists, and infectious disease specialists.

Download Full-text

Before Pigs' Germs Fly: Xenotransplantation and a Call for Federal Action

Cambridge Quarterly of Healthcare Ethics ◽

10.1017/s096318010100411x ◽

2001 ◽

Vol 10 (4) ◽

pp. 441-444

Author(s):

SUSAN E. HERZ

Keyword(s):

Infectious Disease ◽

Third Parties ◽

Third Party ◽

Infectious Disease Specialists ◽

The Common ◽

Animal Organs

When surgeons transplant animal organs into humans, people who did not receive the organs incur risks. These third parties may stand near or far in time or space. No one knows the likelihood, breadth, or nature of the risks in question. The common wisdom among infectious-disease specialists is that in the best of xenotransplant conditions, such third-party risk may be minimized but not eliminated.

Download Full-text